|Access Genetics LLC (dba OralDNA Labs), of Eden Prairie, Minn.||Orarisk COVID-19 RT-PCR Test||Molecular diagnostic||For the qualitative detection of nucleic acid from SARS-CoV-2 in nasopharyngeal swab and nasal swab specimens||Received emergency use authorization from the U.S. FDA|
|Boston Scientific Corp., of Marlborough, Mass.||Watchman Flx||Left atrial appendage closure device||Reduces the risk of stroke in patients with non-valvular atrial fibrillation who need an alternative to oral anticoagulation therapy by permanently closing off the left atrial appendage||Received U.S. FDA approval|
|Channel Medsystems Inc., of Emeryville, Calif.||Cerene||Cryotherapy device||Treatment of heavy menstrual bleeding in the office setting||Received U.S. FDA approval|
|Lifesignals Group Inc., of Fremont, Calif.||Lifesignals Wireless Medical Biosensor LP1250||Single-use patch device with wireless remote monitoring system; allows for 72 hours of data capture||For continuous collection of electrocardiography and heart rate monitoring in ambulatory, hospital, home and health care settings||Received 510(k) clearance from the U.S. FDA|
|Paige Inc., of New York||Fullfocus||Digital pathology image viewer||Allows in vitro diagnostic use of Fullfocus with FDA-authorized Philips Ultra Fast Scanner; assists pathologists in primary diagnosis||Received 510(k) clearance from the U.S. FDA|
For more information about individual companies and/or products, see Cortellis.